SPOCK2 and endometrial cancer: Using immunohistochemistry, Ren et al. demonstrated that the protein level of SPOCK2 in type I endometrial cancer was significantly lower than that of the expression of SPOCK2 protein in normal endometrium (Ren et al. 2020).